Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.517 USD | -3.36% | -14.66% | +123.21% |
01:50pm | Stephens Starts Sensei Biotherapeutics With Overweight Rating, $5 Price Target | MT |
05-09 | Sensei Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+123.21% | 39.38M | |
+4.78% | 111B | |
+12.03% | 105B | |
-12.70% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.57% | 16.96B | |
+4.10% | 13.7B | |
+37.44% | 12.45B |
- Stock Market
- Equities
- SNSE Stock
- News Sensei Biotherapeutics, Inc.
- Oppenheimer Upgrades Sensei Biotherapeutics to Outperform From Perform; Price Target is $5